Le Lézard
Classified in: Health
Subjects: CALENDAR OF EVENTS, HEALTH

Pathways to Cures are in Sight as MS Canada Hosts Annual Day on the Hill with Carnation Pinning


OTTAWA, May 01, 2023 (GLOBE NEWSWIRE) -- Dozens of representatives of MS Canada are fanning across Ottawa May 1st ? May 3rd for the annual Day on the Hill, launching MS Awareness Month activities in support of people affected by multiple sclerosis (MS) - a debilitating neurological disease that impacts more than 90,000 Canadians.

In addition to awareness, MS Canada representatives are appealing for federal research funding, passage of the Canada Disability Benefit legislation, more changes to Employment Insurance sickness benefits, improved home and long-term care, and regulatory reform to streamline access to treatment. 

On May 3rd, federal parliamentarians and government officials will be "self-pinning" carnations to demonstrate solidarity with the MS community and issuing their photos on social media platforms with the tag #TakeActionForMS. The distanced "self-pinning" replaces the traditional annual pinning by MS Canada representatives in the parliamentary foyers. Public officials across Canada and members of the public are also invited to join in showing their support on May 3rd through MS Canada's digital carnation pinning platform.

Key Policy Priorities of MS Canada 

 Key Facts 

Quotations 

Note to Photographers and Producers 
Red carnations will be delivered to House of Commons and Senate lobbies May 3rd for parliamentarians to self-pin.

For further information:
Cathy Bouwers, Director of Public Relations & Strategic Communications 
905-380-2554
[email protected] 



These press releases may also interest you

at 01:05
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation for inavolisib, an investigational oral therapy, in combination with...

at 01:05
Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) ("Innate" or the "Company") today announced that in an abstract published on 14 May 2024 for the European Hematology Association 2024 Congress on SAR443579/IPH6101, submitted by...

at 00:01
Celltrion USA announced today...

at 00:01
SonarMD today presented positive results from two large, longitudinal studies evaluating several major drivers of medical costs in people living with Inflammatory Bowel Disease (IBD) ? defined as people living with ulcerative colitis or Crohn's...

at 00:00
Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") today announced that it signed a memorandum of understanding with YASKAWA Electric Corporation (YASKAWA) to begin discussions on the creation of an innovative cell therapy...

20 mai 2024
Joel's journey to Smile 4 Ever Mexico in Tijuana exemplifies the transformative power of affordable dental care. Struggling with dental problems that affected his quality of life, Joel found a solution in Tijuana, where dental procedures are...



News published on and distributed by: